![Teva Introduces Inhalation Powder and Generic Version in U.S. for Asthma Treatment - Drug Discovery and Development Teva Introduces Inhalation Powder and Generic Version in U.S. for Asthma Treatment - Drug Discovery and Development](https://drugdiscoverytrends.com/wp-content/uploads/2019/10/Inhaler.png)
Teva Introduces Inhalation Powder and Generic Version in U.S. for Asthma Treatment - Drug Discovery and Development
![Teva Launches Two Digital Inhalers in the U.S., AirDuo® Digihaler® (fluticasone propionate and salmeterol) Inhalation Powder and ArmonAir® Digihaler® (fluticasone propionate) Inhalation Powder | Business Wire Teva Launches Two Digital Inhalers in the U.S., AirDuo® Digihaler® (fluticasone propionate and salmeterol) Inhalation Powder and ArmonAir® Digihaler® (fluticasone propionate) Inhalation Powder | Business Wire](https://mms.businesswire.com/media/20200921005170/en/820285/4/TEVA_DH-ArmonAir_Inhaler_TiltR_W.jpg)
Teva Launches Two Digital Inhalers in the U.S., AirDuo® Digihaler® (fluticasone propionate and salmeterol) Inhalation Powder and ArmonAir® Digihaler® (fluticasone propionate) Inhalation Powder | Business Wire
![Albuterol Inhaler Shortage Due to COVID-19 Could Impact People With Asthma | Asthma and Allergy Foundation of America Albuterol Inhaler Shortage Due to COVID-19 Could Impact People With Asthma | Asthma and Allergy Foundation of America](https://community.aafa.org/fileSendAction/fcType/0/fcOid/569479692535494216/primaryPicture/true/fodoid/571872364885442989/imageType/LARGE/inlineImage/true/coronavirus-albuterol-shortage-asthma-medicine-BT.png)